发明名称 Stabilized interface for iontophoresis
摘要 An interface is formed by incorporating (1) a mixture comprising a water-soluble protein and a drug into a matrix, or preferably (2) a mixture comprising a water-soluble protein and a drug to a porous matrix coated with a cationic surfactant or other ionic surfactant. The coating amount of the ionic surfactant is about 0.1 to 50 mu g, and the content of the water-soluble protein is about 0.1 to 1,500 mu g, each per 1 cm2 of the matrix. The water-soluble protein includes an albumin and the drug includes a physiologically active peptide or protein, for example. The use of the stabilized interface inhibits decrease of the drug retaining amount, and insures an effective transdermal drug delivery with a high repeatability and accuracy.
申请公布号 US5837281(A) 申请公布日期 1998.11.17
申请号 US19960614375 申请日期 1996.03.12
申请人 TAKEDA CHEMICAL INDUSTRIES, LTD.;ADVANCE CO., LTD.;TEIKOKU HORMONE MFG. CO., LTD. 发明人 IGA, KATSUMI;MISAKI, MASAFUMI;OKABE, KEIICHIRO;KYO, EMI
分类号 A61N1/30;(IPC1-7):A61K9/70;A61M37/00;B32B3/00 主分类号 A61N1/30
代理机构 代理人
主权项
地址